The Irish companies were chosen from thousands of EU small businesses who pitched for the cash. The grants are for feasibility studies and are Phase 1 of a support programme for SMEs who have ideas for new products but need help to get to the next stage.
Phase 2 of the scheme will see up to € 2.5 million each paid to selected European SMEs who have already developed and tested their product, but need help bringing it to the open market. Those results will be out later this month.
The budget comes from the European Commission’s Horizon 2020 SME Instrument. In all, 185 SMEs across Europe have been selected for funding.
The Irish projects cover a range of topics from disease testing to energy production.
The 4 Irish SMEs are:
Endeco Technologies Ltd, Dublin
Smart-grid optimisation using rate of change of frequency (RoCoF) to rapidly balance power grid network frequency – enabling more widespread use of unpredictable renewables and minimising blackouts.
Allogen Biotech Ltd, Dublin
A study for the technical and business feasibility of a fast-acting consumer test to detect gluten and other contaminants in food.
Hibergene Diagnostics Ltd, Dublin
Real-time molecular diagnostic testing for human infectious diseases using LAMP (Loop Mediated Isothermal Amplification) technology.
DP DesignPro Ltd, Limerick
Commercialization of a viable and proven HydroKinetic Turbine that will harness the power of the world’s rivers, canals and estuaries in a sustainable, innovative and cost-effective way.
The results for Phase 2 of the SME Instrument, where companies get funding up to € 2.5 million to make their products ready for the market, will follow around mid-February 2016. The next cut-off for Phase 1 is 24 February 2016. For more information Lists of beneficiaries will be updated on the Participant Portal